| MDL | MFCD00007535 |
|---|---|
| Molecular Weight | 164.18 |
| Molecular Formula | C2H5NaO3S2 |
| SMILES | SCCS(=O)(O[Na])=O |
Mesna (1-1000 μM) reduces H 2 O 2 , HOCl and OH• concentrations in a dose-dependent manner, with an IC 50 of 32, 21, and 305 μM, respectively in cell-free experiments [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Mesna (150 mg/kg; a single i.p.) protects the rat brain against traumatic injury
[1]
.
Mesna (200 mg/kg; a single i.p.) attenuates the cisplatin-induced ovarian damages in rats
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| Animal Model: | Adult male Wistar Albino rats (250-350 g) are suffered traumatic brain injury (TBI) [1] |
| Dosage: | 150 mg/kg |
| Administration: | A single i.p. |
| Result: |
Decreased tissue malondialdehyde levels.
Increased the activity of glutathione peroxidase and superoxide dismutase. Decreased the levels of nitric oxide, nitric oxide synthetase and xanthine oxidase. Protected the brain tissues well from injury. |
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
H 2 O : ≥ 50 mg/mL ( 304.54 mM )
* "≥" means soluble, but saturation unknown.
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 6.0909 mL | 30.4544 mL | 60.9088 mL |
| 5 mM | 1.2182 mL | 6.0909 mL | 12.1818 mL |
| 10 mM | 0.6091 mL | 3.0454 mL | 6.0909 mL |
Add each solvent one by one: PBS
Solubility: 100 mg/mL (609.09 mM); Clear solution; Need ultrasonic